RGC

Regencell Bioscience Holdings is a biotech company developing traditional Chinese medicine-based therapies for neurocognitive disorders. The company focuses on treating attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) through proprietary herbal formulations. Regencell conducts clinical research to validate the efficacy of traditional remedies using modern scientific methods.